The European Commission has rejected Emotra’s application for approximately 3 MEUR, which we intended to use for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to further develop our hardware and software solutions. Emotra has not yet had the opportunity to analyse the reasoning behind our application’s rejection. However, both Emotra’s Board of Directors and our international partners agree that we should submit a new, revised application as soon as possible. It is quite normal for several applications to be rejected before the European Commission grants one. The fact that our first application was rejected does not affect the Company’s market launch plans.